CTNNB1 and neoplasm: Multiple tumor-intrinsic mechanisms, including MAPK, PTEN/PI3K, WNT/beta-catenin, and IFN signaling pathways, have recently been identified to be related to immunotherapy resistance (Sharma et al., 2017).